Analyze Diet
Frontiers in veterinary science2023; 9; 1086010; doi: 10.3389/fvets.2022.1086010

Association of globulin concentrations with prognosis in horses with lymphoma.

Abstract: Lymphoma is the most common hemopoietic neoplasia in horses. Common clinicopathologic abnormalities in equine lymphoma include hyperglobulinemia, hypoalbuminemia, hyperfibrinogenemia, anemia, thrombocytopenia and lymphocytosis. Hypoglobulinemia has been reported in other species with lymphoma, however it has not been well-described in horses. The objectives of this study were to examine the prevalence of hypoglobulinemia in equine lymphoma, and to identify prognosis and clinicopathological abnormalities associated with serum globulin concentrations. Unassigned: Ninety-six horses with lymphoma were investigated in this retrospective study. Patients were allocated into groups based on serum globulin concentration. Survival analysis was performed to determine risk factors associated with globulin concentration and outcome. Unassigned: Nineteen horses were hypoglobulinemic (≤2.1 g/dL), 63/98 were normoglobulinemic (2.2-4.3 g/dL), and 16/98 were hyperglobulinemic (≥4.4 g/dL). Hyperglobulinemia was associated with a higher anion gap (P = 0.0005), lower bicarbonate (P = 0.006), sodium (P = 0.03) and chloride concentrations (P = 0.002), and higher total protein than hypoglobulinemic horses (P < 0.0001). For location, 37% of horses with mucocutaneous lymphoma were hypoglobulinemic, compared to none in the hyperglobulinemic group (P = 0.02). Survival times were significantly different between low, normal and high globulin groups (P = 0.0002, median [range] survival times: 333 [1-3792], 43 [1-4,001] and 4 [1-129] days, respectively). Significant risk factors for shortened time to death were hyperglobulinemia (HR 2.4, P = 0.02), T cell lymphoma (HR 3.5, P < 0.0001), and multicentric (HR 3.1, P = 0.0008) and mediastinal (HR 6.4, P = 0.006) forms of lymphoma. Lack of chemotherapy was associated with shortened survival time (HR 4.5, P < 0.0001). B cell lymphomas (P < 0.0001) and mucocutaneous lymphoma location (P < 0.0001) were associated with longer survival times. Unassigned: Serum globulin concentrations are associated with location of lymphoma, clinicopathologic abnormalities, and survival times in equine lymphoma.
Publication Date: 2023-01-09 PubMed ID: 36699338PubMed Central: PMC9868912DOI: 10.3389/fvets.2022.1086010Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the prevalence of reduced globulin concentrations (hypoglobulinemia) in horses with lymphoma, and the influence of this on their prognosis and clinicopathological abnormalities. It found that the level of globulin is linked to lymphoma location, clinical features, and survival rates.

Study Design and Information

  • The research is retrospective in nature and involved 96 horses diagnosed with lymphoma.
  • The horses were classified into groups according to their serum globulin concentration.
  • An analysis was then performed to determine the risk factors relating to globulin concentration and the outcomes for the horses.

Findings from the Study

  • Out of the total, 19 horses exhibited hypoglobulinemia, whilst 63 represented normoglobinemia, and 16 were classified under hyperglobulinemia.
  • The study concluded that hyperglobulinemia was associated with certain health parameters such as increased anion gap, decreased bicarbonate, sodium, and chloride concentrations, as well as increased total protein. These horses also lived for a shorter period than horses with normoglobulinemia or hypoglobulinemia.
  • When taken into consideration the lymphoma location, a significant 37% of horses suffering from mucocutaneous lymphoma demonstrated hypoglobulinemia. On the contrary, none of the horses with hyperglobulinemia had this type of lymphoma. This suggests a correlation between lymphoma location and globulin concentrations.

Factors that Influence Survival Time

  • The study showed significant variations in survival times among the horses exhibiting low, normal, and high globulin levels.
  • Risk factors identified for a reduced survival time included: hyperglobulinemia, T cell lymphoma, and multicentric and mediastinal forms of lymphoma.
  • The study also identified that horses not treated with chemotherapy had shorter survival times.
  • Longer survival times were noticed in horses with B cell lymphomas and those with a mucocutaneous lymphoma location.

Conclusion of the Study

  • The research concluded that serum globulin concentrations in horses with lymphoma have an association with lymphoma’s location, clinicopathologic abnormalities, and survival times.

Cite This Article

APA
Wensley FM, Berryhill EH, Magdesian KG. (2023). Association of globulin concentrations with prognosis in horses with lymphoma. Front Vet Sci, 9, 1086010. https://doi.org/10.3389/fvets.2022.1086010

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 9
Pages: 1086010

Researcher Affiliations

Wensley, Fiona M
  • Department of Medicine and Epidemiology, University of California, Davis, Davis, CA, United States.
Berryhill, Emily H
  • Department of Medicine and Epidemiology, University of California, Davis, Davis, CA, United States.
Magdesian, K Gary
  • Department of Medicine and Epidemiology, University of California, Davis, Davis, CA, United States.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 30 references
  1. Valli VE, Bienzle D, Meuten DJ. Tumors of the hemolymphatic system.. In: Tumors in Domestic Animals. 5th ed. Ames, IA: John Wiley & Sons, Inc; (2017). p. 203–10..
  2. Taintor J, Schleis S. Equine lymphoma.. Equine Vet Educ (2011) 23:205–13.
  3. Knowles EJ, Tremaine WH, Pearson GR, Mair TS. A database survey of equine tumours in the United Kingdom.. Equine Vet J (2016) 48:280–4.
    doi: 10.1111/evj.12421pubmed: 25594351google scholar: lookup
  4. Muñoz A, Riber C, Trigo P, Castejón F. Hematopoietic neoplasias in horses: myeloproliferative and lymphoproliferative disorders.. J Equine Sci (2009) 20:59–72.
    doi: 10.1294/jes.20.59pmc: PMC4013965pubmed: 24833969google scholar: lookup
  5. Meyer J, DeLay J, Bienzle D. Clinical, Laboratory, And Histopathologic Features Of Equine Lymphoma.. Vet Pathol (2006) 43:914–24.
    doi: 10.1354/vp.43-6-914pubmed: 17099148google scholar: lookup
  6. Durham AC, Pillitteri CA, San Myint M, Valli VE. Two hundred three cases of equine lymphoma classified according to the world health organization (WHO) classification criteria.. Vet Pathol (2013) 50:86–93.
    doi: 10.1177/0300985812451603pubmed: 22700849google scholar: lookup
  7. Sheard L, McGovern K. Equine lymphoma: a review.. UK Vet Equine (2021) 5:206–14.
  8. Miglio A, Morelli C, Gialletti R, Lauteri E, Sforna M, Marenzoni ML. Clinical and immunophenotypic findings in 4 forms of equine lymphoma.. The Canadian Veterinary Journal (2019) 60:33–40.
    pmc: PMC6294024pubmed: 30651648
  9. Badial PR, Tallmadge RL, Miller S, Stokol T, Richards K, Borges A. Applied protein and molecular techniques for characterization of B cell neoplasms in horses.. Clinical and Vaccine Immunology (2015) 22:1133–45.
    doi: 10.1128/CVI.00374-15pmc: PMC4622111pubmed: 26311245google scholar: lookup
  10. Aleman M, Watson JL. Diseases of the hematopoietic and hemolymphatic systems.. In:Smith BP, editor. Large Animal Internal Medicine. 5th ed. St. Louis, Missouri: Elsevier; (2015). p. 1044–1083..
  11. Traub-Dargatz J, Bertone A, Bennett D, Jones RL, Weingand K, Hall R. Monoclonal aggregating immunoglobulin cryoglobulinemia in a horse with malignant lymphoma.. Equine Vet J (1985) 17:470–3.
  12. Eckersall DP. Proteins, proteomics, and the dysproteinemias.. In: Clinical Biochemistry of Domestic Animals. 6th, ed. Elsevier Inc; (2008). p. 115–151..
  13. Perkins GA, Nydam DV, Flaminio MJ, Ainsworth DM. Serum IgM concentrations in normal, fit horses and horses with lymphoma or other medical conditions.. J Vet Intern Med (2003) 3:337–42.
  14. Keller SM, Vernau W, Moore P. Clonality testing in veterinary medicine: a review with diagnostic guidelines.. Vet Pathol (2016) 53:711–25.
    doi: 10.1177/0300985815626576pubmed: 26933096google scholar: lookup
  15. Valli VE, Jacobs RM, Parodi AL, Vernau W, Moore P. Histological Classification of Hematopoietic Tumors of Domestic Animals.. 2nd series, vol VIII Washington, DC: Armed Forces Institute of Pathology; (2002)..
  16. Thrall MA. Laboratory Evaluation of Plasma and Serum Proteins.. Veterinary Hematology and Clinical Chemistry, 2nd Edition. Philadelphia: Lippincott Williams & Wilkins; (2012). Chapter 29, pg. 461..
  17. . Chemistry Description and Guide: Total Protein.. Idexx VetTest Chemistry Analyzer Operator's Manual. Maine: Idexx Laboratories, Inc; (2014)..
  18. Bakker AJ, Gorgels JP, Draaisma J, Jongendijk M, Altena L, Hamersma A. Simple method for correcting total protein in plasma for actual fibrinogen concentration.. Clin Chem (1992) 38:2221–3.
    doi: 10.1093/clinchem/38.11.2221pubmed: 1424114google scholar: lookup
  19. Lumsden JH, Rowe R, Mullen K. Hematology and biochemistry reference values for the light horse.. Can J comp Med (1980) 44:32–42.
    pmc: PMC1320032pubmed: 7397597
  20. Miller CA, Durham AC, Schaffer PA, Ehrhart EJ, Powers BE, Duncan CG. Classification and clinical features in 88 cases of equine cutaneous lymphoma.. J Vet Diagn Invest (2015) 27:86–91.
    doi: 10.1177/1040638714561653pubmed: 25525142google scholar: lookup
  21. Hamblin AD, Hamblin TJ. The immunodeficiency of chronic lymphocytic leukaemia.. Br Med Bullet (2008) 87:49–62.
    doi: 10.1093/bmb/ldn034pubmed: 18755702google scholar: lookup
  22. Nguyen A, Martin-Silva N, de Boysson H, Deshayes S, Gac A, Reboursiere E. Low total gamma globulin level discovery at diffuse large B-cell lymphoma diagnosis predicts high risk of infection-related death: data from a monocentric retrospective study.. Swiss Med Wkly (2022) 152:w30143.
  23. Griffiths H, Brennan V, Lea J, Bunch C, Lee M, Chapel H. Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.. Blood (1989) 73:366–8.
    doi: 10.1182/blood.V73.2.366.366pubmed: 2492832google scholar: lookup
  24. Luethy D, Frimberger AE, Bedenice D. Retrospective evaluation of clinical outcome after chemotherapy for lymphoma in 15 equids (1991-2017).. J Vet Intern Med (2019) 33:953–960.
    doi: 10.1111/jvim.15411pmc: PMC6430950pubmed: 30636061google scholar: lookup
  25. Parikh SA, Leis JF, Chaffee KG, Call TG, Hanson CA, Ding W. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: natural history, clinical correlates, and outcomes.. Cancer (2015) 1: 2883–91.
    doi: 10.1002/cncr.29438pmc: PMC4545721pubmed: 25931291google scholar: lookup
  26. Singh N, Mott SL, McCarthy AN, Syrbu S, Habermann TM, Feldman AL. Prevalence and the impact of hypogammaglobulinemia in newly diagnosed, untreated diffuse large B cell lymphoma.. Blood (2019) 134:1604.
    doi: 10.1182/blood-2019-122737google scholar: lookup
  27. Dimeski G, Barnett RJ. Effects of total plasma protein concentration on plasma sodium, potassium and chloride measurements by an indirect ion selective electrode measuring system.. Crit Care Resusc (2005) 7:12–5.
    doi: 10.3316/519233044885156pubmed: 16548813google scholar: lookup
  28. Wang C, Lv Z, Zhang Y. Type B lactic acidosis associated with diffuse large B-cell lymphoma and the Warburg effect.. J Int Med Res (2022) 3:7749.
    doi: 10.1177/03000605211067749pmc: PMC8743961pubmed: 34986706google scholar: lookup
  29. Chan FH, Carl D, Lyckholm LJ. Severe lactic acidosis in a patient with B-cell lymphoma: a case report and review of the literature.. Case Rep Med (2010).
    doi: 10.1155/2009/534561pmc: PMC2804112pubmed: 20069124google scholar: lookup
  30. Miles RR, Roberts RF, Putnam AR, Roberts WL. Comparison of serum and heparinized plasma samples for measurement of chemistry analytes.. Clin Chem (2004).
    doi: 10.1373/clinchem.2004.036533pubmed: 15331516google scholar: lookup